Rain Enhancement Technologies Holdco Inc (RAIN)

NAPLES, FL, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Rain Enhancement Technologies Holdco, Inc. (Nasdaq: RAIN) (the “Company”) announced today that it received a notice (the “Notice”) on August 19, 2025 from the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has not regained compliance with Nasdaq Listing Rule 5450(b)(2)(A), requiring the Company to maintain a market value of listed securities of at least $50 million, and Nasdaq Listing Rule 5450(b)(2)(B), requiring the Company to maintain a market value of publicly held shares of at least $15 million. The Notice provides that the Company has until 4:00 p.m. Eastern Time on August 26, 2025 to appeal the Staff's delisting determination.

Company Expands WETA Platform Applications Beyond Rainfall Generation to Address Multi-Billion Dollar Fog Impact on Global Transportation and Industry NAPLES, FL / ACCESS Newswire / August 20, 2025 / Rain Enhancement Technologies Holdco, Inc. (NASDAQ:RAIN) ("RET" or the "Company"), a leading provider of ionization rainfall generation technology, today announced plans to conduct its first fog mitigation pilot in Australia this month, weather permitting. This groundbreaking initiative marks RET's expansion of its Weather Enhancement Technology Array (WETA) platform beyond rainfall generation to address the significant economic impact of fog on transportation, agriculture, manufacturing, and energy production worldwide.

Insurance and Agriculture Leaders Bring Decades of Experience in Key Target Markets for Rainfall Generation Technology NAPLES, FL / ACCESS Newswire / August 12, 2025 / Rain Enhancement Technologies Holdco, Inc. (NASDAQ:RAIN) ("RET" or the "Company"), a leading provider of ionization rainfall generation technology, today announced that Bob Reardon, Chief Executive Officer of ISG, and Marc Peperzak, Chairman and Founder of Aurora Organic Dairy, have joined the Company's Board of Directors. These strategic appointments bring deep expertise in the insurance and agriculture sectors, two critical target markets for RET's weather enhancement solutions.

Veteran Engineer Brings Over 20 Years of Experience and Deep WETA Platform Expertise To Advisory Role NAPLES, FL / ACCESS Newswire / August 7, 2025 / Rain Enhancement Technologies Holdco, Inc. (NASDAQ:RAIN) ("RET" or the "Company"), a leading provider of ionization rainfall generation technology, today announced the appointment of Scott Morris as Senior Technical Advisor of Rain Enhancement Technologies, Inc., the Company's wholly-owned subsidiary. This newly created position recognizes the Company's commitment to advancing its Weather Enhancement Technology Array (WETA) platform and scaling its rainfall generation solutions globally.

NAPLES, Fla.--(BUSINESS WIRE)--Rain Enhancement Technologies Holdco, Inc. (“RET Holdco” or the “Company”) (Nasdaq: RAIN, RAINW), an emerging company developing rainfall generation technology, today announced that Randy Seidl has been appointed as Chief Executive Officer (“CEO”) of RET Holdco and of its wholly-owned subsidiary, Rain Enhancement Technologies, Inc. (“RET”). Seidl has served as Co-Chief Executive Officer and a member of the Board of Directors since January 2, 2025. Seidl brings ove.

CHICAGO--(BUSINESS WIRE)--Pathos AI, Inc. (“Pathos”) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (“Merger Sub”), successfully completed its tender offer to acquire all outstanding shares of the common stock of Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”) for $1.16 per share in cash plus one contingent value right per share (each, a “CVR”), which CVR shall represent the right to receive potential payments pursuant to the terms and subject to the conditions.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Rain Oncology Inc. (NasdaqGS: RAIN) to Pathos AI, Inc. Under the terms of the proposed transaction, shareholders of Rain will receive $1.16 in cash plus a non-tradeable contingent value right for potential cash payments of up to approximately $0.17, for each share of Rain that they own. KSF is seeking to deter.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Rain Oncology Inc. (NasdaqGS: RAIN) to Pathos AI, Inc. Under the terms of the proposed transaction, shareholders of Rain will receive $1.16 in cash plus a non-tradeable contingent value right for potential cash payments of up to approximately $0.17, for each share of Rain that they own. KSF is seeking to deter.

MILWAUKEE , Dec. 14, 2023 /PRNewswire/ -- Ademi LLP is investigating Rain (NASDAQ: RAIN) for possible breaches of fiduciary duty and other violations of law in its transaction with Pathos. Click here to learn how to join the https://www.ademilaw.com/case/rain-oncology-inc or call Guri Ademi toll-free at 866-264-3995.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Rain Oncology Inc. (NASDAQ: RAIN) to Pathos AI, Inc. for $1.16 in cash per share plus a non-tradeable contingent value right for potential cash payments of up to approximately $0.17 per share is fair to Rain shareholders. Halper Sadeh encourages Rain shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060.

NEWARK, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos”) will acquire Rain for $1.16 in cash per share plus a non-tradeable contingent value right (a “CVR”) for potential cash payments of up to approximately $0.17 per share.

NEWARK, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NasdaqGS: RAIN) (Rain) today reported financial results for the third quarter ended September 30, 2023, along with an update on the Company's key developments and business operations.

Penny stocks, defined as stocks trading under $5 per share, offer traders huge upside potential but also carry significant risks. One strategy used by some investors to identify promising penny stocks is tracking insider trading activity through SEC filings.

NEWARK, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Rain Oncology, Inc. (NasdaqGS: RAIN) (“Rain”) confirmed that it has received an unsolicited proposal from Tang Capital, LP on behalf of Concentra Biosciences LLC to acquire all outstanding shares of common stock of Rain for $1.25 per share in cash, plus a contingent value right (“CVR”) representing the right to receive 80% of the net proceeds payable from any license or disposition of Rain's programs.

NEW YORK , Sept. 11, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the "Class Period"), of the important September 12, 2023 lead plaintiff deadline.

NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rain-lawsuit-submission-form?prid=47662&wire=1 or contact Joseph E. Levi, Esq.